eli lilly retatrutide press release 2024 2025 Scientific Diabetes Disclosures Eli Lilly Exec Talks New

The metabolic accelerator that makes every other body contouring treatment in your menu work harder

The majority of patients achieve their weight loss and health goals within a year and have better long-term success in maintaining their results than those who have not taken a GLP-1 medication

Practical Tips If Your Provider Says Occasional Alcohol Is Okay If your healthcare provider says occasional alcohol is reasonable for you, use caution

In the REDEFINE 1 clinical trial, patients treated with the combination achieved a mean weight loss of 22.7% at 68 weeks, and more than 40% of participants achieved at least a 25% reduction in body weight